Last reviewed · How we verify
Hyaluronate (HYALURONIC ACID)
Hyaluronate, also known as hyaluronic acid, is a naturally occurring polysaccharide used in ophthalmic surgery. It is a small molecule drug that works by providing hydration and cushioning to the eye, allowing for smooth lens movement and reducing the risk of complications during surgical procedures. Hyaluronate is FDA-approved for use in operations on the lens and surgical procedures on the eye proper. It is a patented product, but its commercial status is not explicitly stated. Key safety considerations include the risk of allergic reactions and eye irritation.
At a glance
| Generic name | HYALURONIC ACID |
|---|---|
| Drug class | hyaluronic acid |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
| Annual revenue | 1177 |
Approved indications
- Operation on lens
- Surgical procedure on eye proper
Common side effects
Key clinical trials
- Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate. (NA)
- Hyaluronic Acid in Endodontic Microsurgery (NA)
- Clinical Investigation on Lips Treated With HA-filler (NA)
- Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? (NA)
- A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma (NA)
- USC-Exos in Corpus Spongiosum Reconstruction for Hypospadias (NA)
- Early vs Delayed Intravesical Blad-Care During BCG Therapy (NA)
- A Clinical Investigation of the Decoria® Aesthetic Group (DAG) for Correction of Nasolabial Folds (NLF) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
| SEC EDGAR | Revenue + earnings |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hyaluronate CI brief — competitive landscape report
- Hyaluronate updates RSS · CI watch RSS